A new study that followed a cohort of more than 110,000 people establishes significant disparities in the risk of anal cancer for people with HIV and for men who have sex with men with HIV, depending on the region of the ...
May 7, 2024
0
0
A team of researchers including UCI project scientist Rachita Sumbria, Ph.D. and UCI neurologist Mark J. Fisher, MD have provided, for the first time, evidence that blood deposits in the brain may not require a blood vessel ...
Sep 25, 2018
0
12
In a study published in the Clinical Journal of the American Society of Nephrology (CJASN) that included older adults with kidney failure, symptoms related to their condition worsened in the year before patients started dialysis, ...
Nov 10, 2022
0
3
Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 ...
May 16, 2020
0
2
In 2010, scientists discovered that African Americans who are born with certain variants of a gene called apolipoprotein L1 (APOL1) have a higher-than-average risk for experiencing chronic kidney disease (CKD). Now, in a ...
Mar 4, 2022
0
30
Even months after critical illness for sepsis, children are at risk for new or worsening medical conditions, a study suggests.
Oct 13, 2022
0
34
New research suggests that attempts to normalize blood pressure, and cholesterol may have negative long-term effects on kidney health in adults with type 2 diabetes who are at high risk for cardiovascular disease. The results ...
Oct 25, 2018
0
0
Investigators have found that dasatinib, a drug commonly used to treat chronic myeloid leukemia, is strongly associated with kidney injury.
Sep 12, 2023
0
9
The COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevention services, and directly, by threatening individual health. An effective response to these ...
Apr 8, 2021
0
6
(HealthDay)—Semaglutide is noninferior to placebo for patients with type 2 diabetes at high cardiovascular risk, according to a study published online Sept. 16 in the New England Journal of Medicine. The research was published ...
Sep 17, 2016
0
2
